Wave Life Sciences’ Weight Loss Drug Phase 1 Clinical Data Triggers Stock Volatility, Yet Differentiated Path Still Shows Promise Apr 1, 2026 Life Science
High Volatility, High Reward: Two Biotech Stocks for the Risk-Tolerant Investor Mar 26, 2026 Life Science
Who Will Be the Next Oncology Giant? Axsome and Madrigal Could Overtake by 2026 Mar 25, 2026 Life Science
Tarsus Pharmaceuticals Chief Human Resources Officer Sells Shares, Transaction Highlights Company’s Commercial Momentum Mar 25, 2026 Life Science
Is GeneDx, the Stock Cathie Wood Bought for 7 Straight Days, Actually Cheap? Mar 12, 2026 Life Science
Seeking a Bottom in Choppy Markets? Two Long-Term Picks with “Anti-Fragile” Qualities Mar 12, 2026 Life Science, Technology
This Cathie Wood-Favored Gene-Editing Stock Is Up 47% This Year. Is It Poised to Take Off? Mar 8, 2026 Life Science
